Skip to content
healthcare.dev

Doxazosin

NDC 51655-130, Doxazosin Mesylate, tablet, from Northwind Health Company, LLC.

Product NDC
51655-130
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE4 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
51655-130-265165501302690 TABLET in 1 BOTTLE, PLASTIC (51655-130-26)
51655-130-525165501305230 TABLET in 1 BOTTLE, PLASTIC (51655-130-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6c9856e-9154-f349-e053-6294a90a9f2c

Use it

Look up 51655-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.